JPM UK Equity Core Fund E Quarterly - Net IncomeRegister to Unlock Ratings |
Performance History | 31/10/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | -9.7 | 19.2 | 0.7 | 7.4 | 8.3 | |
+/-Cat | -0.6 | 1.2 | 2.7 | -0.8 | 0.9 | |
+/-B’mrk | - | - | - | -0.3 | 0.1 | |
Category: UK Large-Cap Equity | ||||||
Category Benchmark: Morningstar UK All Cap TME ... |
Key Stats | ||
NAV 22/11/2024 | GBP 0.59 | |
Day Change | 1.29% | |
Morningstar Category™ | UK Large-Cap Equity | |
IA (formerly IMA) Sector | UK All Companies | |
ISIN | GB00BYM41F95 | |
Fund Size (Mil) 22/11/2024 | GBP 1174.43 | |
Share Class Size (Mil) 22/11/2024 | GBP 18.65 | |
Max Initial Charge | - | |
Ongoing Charge 01/01/2024 | 0.36% |
Investment Objective: JPM UK Equity Core Fund E Quarterly - Net Income |
To provide capital growth and outperform the FTSE™ All-Share Index (Net) over the long- term (5-10 years), after fees, by investing at least 80% of the Fund's assets in a portfolio of UK companies. At least 80% of assets invested in equities of companies that are domiciled, or carrying out the main part of their economic activity, in the UK. |
Returns | ||||||||||||||||
|
Management | ||
Manager Name Start Date | ||
James Illsley 01/07/2013 | ||
Anthony Lynch 29/09/2017 | ||
Click here to see others | ||
Inception Date 20/04/2017 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
FTSE All Share NR GBP | Morningstar UK All Cap TME NR GBP |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for JPM UK Equity Core Fund E Quarterly - Net Income | 31/10/2024 |
|
|
Top 5 Holdings | Sector | % |
AstraZeneca PLC | Healthcare | 6.90 |
Shell PLC | Energy | 6.75 |
HSBC Holdings PLC | Financial Services | 5.64 |
Unilever PLC | Consumer Defensive | 4.68 |
JPM GBP Liquidity LVNAV X (dist.) | 3.34 | |
Increase Decrease New since last portfolio | ||
JPM UK Equity Core Fund E Quarterly - Net Income |